CMS Increases Medicare Payment for High-Production Coronavirus Tests
On April 15, 2020, CMS issued Ruling No. CMS-2020-01-R stating that Medicare will pay $100 for COVID-19 clinical diagnostic lab tests that use high-throughput technologies for rapid diagnosis of large numbers of COVID-19 cases. High-throughput lab tests can process more than 200 specimens a day and are expected to be instrumental in diagnosing and controlling the spread of COVID-19, especially in facilities such as nursing homes that house large numbers of people vulnerable to COVID-19. Medicare Administrative Contractors will continue to develop payment amounts for other COVID-19 laboratory tests.